|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | |||||||||
| Current liabilities | |||||||||
| Accrued expenses | |||||||||
| Promissory note - related party | |||||||||
| Accrued offering costs | |||||||||
| Total current liabilities | |||||||||
| Convertible note - related party | |||||||||
| Deferred underwriting fees payable | |||||||||
| TOTAL LIABILITIES | |||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.81 and $10.62 per share at June 30, 2026 and December 31, 2025, respectively | |||||||||
| SHAREHOLDERS’ DEFICIT | |||||||||
| Ordinary shares, value | |||||||||
| Class A Ordinary Shares | |||||||||
| Class B Ordinary Shares | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| TOTAL SHAREHOLDERS’ DEFICIT | |||||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...
